Inhibitor Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Inhibitor Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Inhibitor Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$813K, a 7.07% decline year-over-year.
  • Inhibitor Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.45M, a 34.9% decline year-over-year.
  • Inhibitor Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$3.4M, a 418% decline from 2022.
  • Inhibitor Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$658K, a 102% decline from 2021.
  • Inhibitor Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$325K, a 69.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.4M -$2.75M -418% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$658K -$333K -102% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$325K +$734K +69.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$1.06M +$1.69M +61.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$2.75M +$1.82M +39.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 -$4.56M +$555K +10.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$5.12M +$1.9M +27.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$7.02M -$3.07M -77.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-16
2015 -$3.95M -$11.8K -0.3% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-17
2014 -$3.94M -$1.94M -96.9% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-01
2013 -$2M -$1.44M -257% Jan 1, 2013 Dec 31, 2013 10-K 2015-02-13
2012 -$561K Jan 1, 2012 Dec 31, 2012 10-K 2014-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.